Cargando…

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19

BACKGROUND: New-onset atrial fibrillation (AF) during COVID-19 infection is associated with worse cardiovascular outcomes and mortality, with new-onset AF being associated with worse clinical outcomes than recurrent AF. However, it is not known whether a prior history of AF is an independent cardiov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cutler, Michael J., May, Heidi T., Bair, Tami L., Crandall, Brian G., Osborn, Jeffrey S., Miller, Jared D., Mallender, Charles D., Muhlestein, Joseph B., Anderson, Jeffrey L., Knowlton, Kirk U., Knight, Stacey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513337/ https://www.ncbi.nlm.nih.gov/pubmed/36188756 http://dx.doi.org/10.1016/j.ijcha.2022.101127

Ejemplares similares

Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation
por: Varela, Daniel L., et al.
Publicado: (2022)

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications
por: Bunch, T. Jared, et al.
Publicado: (2016)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2023)

IMPACT OF THE COVID PANDEMIC ON DEPRESSIVE SYMPTOMS AND SEVERITY
por: May, Heidi Thomas, et al.
Publicado: (2023)

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

A COMPARISON OF CARDIOVASCULAR OUTCOMES AMONG SARS-COV-2 POSITIVE PATIENTS, SARS-COV-2 NEGATIVE PATIENTS, AND A HISTORICAL COHORT
por: May, Heidi Thomas, et al.
Publicado: (2023)

Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study
por: Bunch, T. Jared, et al.
Publicado: (2019)

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
por: Bunch, Thomas Jared, et al.
Publicado: (2022)

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry
por: Horne, Benjamin D, et al.
Publicado: (2022)

Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort
por: Horne, Benjamin D, et al.
Publicado: (2022)

Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial
por: Horne, Benjamin D., et al.
Publicado: (2021)

Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial
por: Horne, Benjamin D., et al.
Publicado: (2023)

Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis
por: Muhlestein, Joseph B., et al.
Publicado: (2022)

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population
por: Muhlestein, Joseph B., et al.
Publicado: (2020)

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
por: Le, Viet T., et al.
Publicado: (2023)

Improving CHA(2)DS(2)-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation
por: Graves, Kevin G, et al.
Publicado: (2018)

Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

A Small but Significantly Greater Incidence of Inflammatory Heart Disease Identified After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2
por: Knowlton, Kirk U, et al.
Publicado: (2021)

ROUTINE PERIODIC FASTING IS ASSOCIATED WITH A LOWER RISK OF INPATIENT HOSPITALIZATION FOR THE PRIMARY DIAGNOSIS OF HEART FAILURE FOLLOWING COVID-19 DIAGNOSIS
por: Horne, Benjamin Davies, et al.
Publicado: (2023)

A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL(3)+IDL])
por: May, Heidi T, et al.
Publicado: (2013)

STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
por: Knight, Stacey, et al.
Publicado: (2015)

Repeated Measurement of the Intermountain Risk Score Enhances Prognostication for Mortality
por: Horne, Benjamin D., et al.
Publicado: (2013)

A highly predictive cardiac positron emission tomography (PET) risk score for 90-day and one-year major adverse cardiac events and revascularization
por: McCubrey, Raymond O., et al.
Publicado: (2022)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Association of household income and adverse outcomes in patients with atrial fibrillation
por: LaRosa, Anna Rose, et al.
Publicado: (2020)

Atrial Myopathy Underlying Atrial Fibrillation
por: Rivner, Harold, et al.
Publicado: (2020)

Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes
por: Bunch, T Jared, et al.
Publicado: (2019)

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk
por: Horne, Benjamin D, et al.
Publicado: (2018)

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19
por: Wang, Lucas, et al.
Publicado: (2023)

Vitamin D supplementation protects against reductions in plasma 25‐hydroxyvitamin D induced by open‐heart surgery: Assess‐d trial
por: Barker, Tyler, et al.
Publicado: (2021)

Mitral annular calcification is associated with atrial fibrillation and major cardiac adverse events in atrial fibrillation patients: A systematic review and meta-analysis
por: Li, Yimin, et al.
Publicado: (2019)

Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort
por: Li, Linzi, et al.
Publicado: (2023)

First report of dabigatran reversal in iatrogenic pericardial tamponade during catheter ablation of atrial fibrillation
por: Miller, Jared D., et al.
Publicado: (2017)

Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial
por: Bartholomew, Ciera L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vkmhneave7n9ekfapvlb2d5ch7